Cartography Biosciences
5 known investors
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets. The company combines genomics data analysis with therapeutic design to create more targeted treatments for cancer patients.
Founders & leadership
KP
Kevin ParkerChief Executive Officer
MM
Max MumbachFounding Scientist, Target Discovery
JV
Jeffrey VerboonFounding Scientist, Computational Biology
AS
Ansu SatpathyFounder
Investors · 5
In the news
- Cartography Biosciences Receives Investment From Samsung Venturesfinsmes.com · 2026
- Cartography Biosciences raises $67M from Pfizer, Amgen for cancer drug - San Francisco Business Timesbizjournals.com · 2025
- Cartography secures $67M in pursuit of ‘differentiated’ cancer drugs | BioPharma Divebiopharmadive.com · 2025
- Cartography Raises $67M in Series B Fundingfinsmes.com · 2025
- Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinicbusinesswire.com · 2025
- Cartography Biosciences - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2022